Plant Advanced Techonolgies : Hausse du Chiffre d’Affaires Combiné au 30 juin 2024
July 22, 2024 12:36 ET
|
Plant Advanced Technologies
Vandœuvre-lès-Nancy, le 22 juillet 2024 - 18 : 30 (CET) Communiqué de pressePour diffusion immédiate Hausse du Chiffre d’Affaires Combiné au 30 juin 2024 Chiffre d’affaires semestriel non audité du...
Amendment of Disclosures in Past Management Information Circulars
July 16, 2024 18:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- As a result of a review by the British Columbia Securities Commission, BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:...
Alvotech Announces Closing of Private Debt Financing
July 11, 2024 04:45 ET
|
Alvotech
REYKJAVIK, Iceland, July 11, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
BetterLife Announces Closing of a Private Placement
July 02, 2024 18:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Alvotech Issues New Shares to Holders of Convertible Bonds
July 01, 2024 17:35 ET
|
Alvotech
REYKJAVIK, Iceland, July 01, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
June 26, 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
SAb Biotherapeutics Rebrands as SAB BIO
June 20, 2024 07:20 ET
|
SAB Biotherapeutics, Inc.
New name, logo and website updates, stock symbol will remain SABS With new brand identity, SAB BIO continues drive towards serious unmet needs in type 1 diabetes MIAMI, June 20, 2024 (GLOBE...
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe
June 18, 2024 04:01 ET
|
Alvotech
Advanz Pharma secures rights to commercialize Alvotech’s biosimilar candidate for Eylea® in Europe Advanz Pharma will leverage its existing specialty and hospital capabilities in Europe to ensure...
BetterLife Announces Closing of a Private Placement
June 14, 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 14, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Alvotech Announces Strategic Refinancing Agreement
June 07, 2024 04:00 ET
|
Alvotech
REYKJAVIK, Iceland, June 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...